Neurotech International Limited (ASX:NTI)
Australia · Delayed Price · Currency is AUD 0.0130
0.00 (0.00%)
At close: Mar 27, 2026
Neurotech International Market Cap
Neurotech International has a market cap or net worth of 16.85 million as of March 27, 2026. Its market cap has decreased by -52.44% in one year.
Market Cap
16.85M
Enterprise Value
10.51M
Revenue
7.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since November 4, 2016, Neurotech International's market cap has decreased from 25.09M to 16.85M, a decrease of -32.83%. That is a compound annual growth rate of -4.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 16.85M | -7.14% |
| Dec 31, 2025 | 18.15M | -68.34% |
| Dec 31, 2024 | 57.32M | -6.85% |
| Dec 29, 2023 | 61.53M | 8.18% |
| Dec 29, 2022 | 56.88M | 35.96% |
| Dec 31, 2021 | 41.83M | 65.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 4, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avecho Biotechnology | 34.90M |
| Algorae Pharmaceuticals | 27.47M |
| NeuroScientific Biopharmaceuticals | 24.94M |
| Argenica Therapeutics | 23.12M |
| Noxopharm | 17.82M |
| Patrys | 16.06M |
| Bio-Gene Technology | 10.68M |
| AdAlta | 10.20M |